论文部分内容阅读
目的观察多巴酚丁胺与酚妥拉明治疗肺心病并心力衰竭疗效观察。方法对重症肺心病心衰患者在常规治疗基础上加用多巴酚丁胺、酚妥拉明治疗,疗程7d。结果观察组总有效率95.0%,对照组总有效率75.0%,二组比较差异有统计学意义(P<0.05)。结论多巴酚丁胺与酚妥拉明治疗肺心病并心力衰竭临床疗效肯定,值得推广。
Objective To observe the therapeutic effect of dobutamine and phentolamine on pulmonary heart disease and heart failure. Methods The patients with severe pulmonary heart disease were treated with dobutamine and phentolamine on the basis of routine treatment for 7 days. Results The total effective rate was 95.0% in the observation group and 75.0% in the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion Dobutamine and phentolamine treatment of pulmonary heart disease and heart failure clinical efficacy is worthy of promotion.